Can Hospitals Charge Huge Margins on Medical Consumables? Here’s What the Law Says

Hospital Bills Under Scrutiny: What Protection Do Patients Have Against Excessive Charges?

Hospital Consumables: Does the Government Control the Gap Between Actual Cost and MRP?

The recent concerns raised by Maharashtra FDA Commissioner Tukaram Mundhe over the prices of hospital consumables have brought an important question into focus: if a hospital buys a medical product at a much lower price than its printed MRP, how much can it legally charge the patient?

The answer is not the same for every medical product. India has price controls for certain medicines and medical devices, but there is no universal government ceiling on the trade margin or MRP of every consumable used by hospitals.

₹11 Product, ₹325 MRP: Why the Difference Matters

Mundhe has highlighted instances where the procurement price of a hospital consumable was dramatically lower than its printed MRP. Such examples raise questions about how prices are determined at different stages—from manufacturer to distributor, hospital and ultimately patient.

A large difference between a manufacturer's or hospital's purchase price and MRP does not automatically mean that the hospital has legally overcharged the patient. MRP is the maximum retail price at which a packaged product can generally be sold; it is not necessarily the manufacturer's production cost or the hospital's purchase price.

However, when a medical product is effectively unavoidable during treatment, the patient may have very little ability to compare prices or choose another supplier. That makes transparency particularly important.

What Does the Government Control?

The National Pharmaceutical Pricing Authority (NPPA) regulates prices of medicines covered under the Drugs (Prices Control) Order, 2013. It fixes ceiling prices for scheduled medicines and has powers to regulate prices in specified circumstances. 

Medical devices are also treated as drugs for certain regulatory purposes. Since April 2020, medical devices have been brought under the DPCO framework for quality control and price monitoring. For non-scheduled products, the government has historically monitored increases in MRP, including the rule restricting annual MRP increases beyond 10% under the relevant provisions.

But there is an important distinction.

Price monitoring is not the same thing as fixing the purchase-to-MRP margin.

NPPA itself has explained that while all medical devices fall within the regulatory framework, only certain devices have fixed ceiling prices. Its published material identifies devices such as cardiac stents, drug-eluting stents, condoms and intrauterine devices as scheduled devices with notified ceiling prices, while other devices generally do not have a fixed NPPA price. 

So Can a Hospital Charge the Printed MRP?

For a packaged medicine or device that is sold as a product, the printed MRP is generally the maximum price, subject to applicable laws and rules. A seller cannot simply charge more than the applicable MRP.

But the situation becomes more complicated inside a hospital.

A hospital bill may contain separate components such as:

medicines;

medical devices and consumables;

doctor/professional charges;

nursing charges;

room charges;

procedure charges;

diagnostic services; and

other hospital services.

Therefore, the purchase price of a syringe or IV set cannot automatically be treated as the maximum amount that the hospital is allowed to recover for the entire medical service in which it is used.

The legal treatment can also differ depending on whether the item is being sold as a packaged product or is being used as part of a medical procedure.

The Government Has Recognised the Problem

This is not a new concern.

An NPPA document has previously noted that certain hospital consumables were outside direct price control and that hospital charges and diagnostic services could fall outside NPPA's pricing jurisdiction. It specifically observed that some consumables were not under price control or MRP monitoring because they were not classified as drugs under the relevant framework at that time.

More recently, a 2026 parliamentary committee recommendation highlighted concerns about the gap between production costs and MRPs of medical devices. The committee recommended studying manufacturing costs, distribution margins and retail mark-ups and examining mechanisms to curb excessive margin

That is significant because it shows that the issue is not simply about whether a hospital has exceeded an MRP. It is also about how the MRP itself is determined.

What About Stents and Other Price-Controlled Devices?

There are areas where the government has imposed much stronger controls.

For example, coronary stents are included in the price-control framework, and NPPA fixes their ceiling prices. The government has stated that manufacturers, marketers and importers must sell these devices within the notified ceiling price, plus applicable GST. 

NPPA also maintains a system for monitoring overcharging and publishes information about overcharging cases. 

So the system is not completely without government control. The problem is that the degree of control varies considerably depending on the particular medicine, device or consumable.

Where Does the Patient Get Protection?

Patients have several avenues when they believe they have been wrongly charged.

If the issue concerns a medicine or regulated medical device, a complaint can potentially be taken up with the relevant drug-control authority/NPPA, depending on the product and nature of the complaint.

For hospital services, billing disputes and deficiencies in service, consumer-protection mechanisms can also become relevant. The precise legal remedy depends on the facts, the nature of the hospital and the item being charged.

Patients should therefore ask for:

An itemised hospital bill

The name and brand of the medicine/device/consumable

The printed MRP

Quantity used

Any applicable GST

Whether the item was billed separately or included in a procedure/package

Copies of prescriptions and investigation reports where relevant

Keeping the original bill and product packaging can be particularly useful if a complaint is subsequently made.

The Bigger Question: Who Decides a “Fair” Margin?

This is where the current debate becomes complicated.

Suppose a hospital purchases a product for ₹10 and the manufacturer prints an MRP of ₹100. The ₹90 difference does not automatically represent ₹90 of hospital profit. The supply chain may include manufacturing, transportation, distributor margins, inventory costs, wastage, storage, taxes and other expenses.

But if the MRP itself is disproportionately high compared with the underlying supply-chain costs, merely saying that the hospital charged “within MRP” may not fully answer the broader question of whether the pricing structure is reasonable or transparent.

That is precisely why the debate over hospital consumables is moving beyond simple MRP enforcement toward questions of trade margins, procurement prices, disclosure and competition.

What Could Greater Transparency Look Like?

Possible regulatory approaches include:

requiring hospitals to disclose the MRP and quantity of consumables separately;

displaying alternative brands and prices where medically appropriate;

monitoring unusually large gaps between procurement prices and MRPs;

studying manufacturer, distributor and hospital margins;

strengthening complaint mechanisms;

imposing price ceilings on additional categories of essential medical devices where justified; and

ensuring that emergency patients are not disadvantaged because they cannot compare prices.

The parliamentary committee has specifically recommended examining pricing structures, including manufacturing costs, distribution margins and retail mark-ups, and considering measures against excessive margins. 

Yes, the Indian government does have mechanisms to control and monitor prices of medicines and certain medical devices but there is no blanket government ceiling covering every hospital consumable and every hospital charge.

Er M.A.Shakeel.

M.D.

Frame and Share.